メーカー別の市場細分化では、レポートは次の企業をカバーしています-
Teva
Novartis
Pfizer
Johnson & Johnson
Mylan
North China Pharmaceutical Group
Dr. Reddy\'s Laboratories
Roche
Aurobindo pharma
Sun Pharmaceutical Industries
Boehringer Ingelheim GmbH
Bayer
BASF
DSM
Zhejiang Medicine
Biocon
Johnson Matthey
Hisun Pharmacy
Cambrex
Shandong Xinhua Pharmaceutical
Lonza group
Huahai Pharmaceutical
Haerbin Pharmaceutical Group
Cipla
Tian Yao
Lupin
North East Pharmaceutical
Albemarle
Shandong Lukang Pharmaceutical
Jiangsu Hengrui Medicine
1 Study Coverage
1.1 Active Pharmaceutical Ingredient Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Active Pharmaceutical Ingredient Market Size Growth Rate by Product
1.4.2 Synthetic API
1.4.3 Biotech API
1.4.4 Other
1.5 Market by End User
1.5.1 Global Active Pharmaceutical Ingredient Market Size Growth Rate by End User
1.5.2 Chemical
1.5.3 Deodorant
1.5.4 Dailylife
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Active Pharmaceutical Ingredient Market Size
2.1.1 Global Active Pharmaceutical Ingredient Revenue 2015-2028
2.1.2 Global Active Pharmaceutical Ingredient Sales 2015-2028
2.2 Active Pharmaceutical Ingredient Growth Rate by Regions
2.2.1 Global Active Pharmaceutical Ingredient Sales by Regions
2.2.2 Global Active Pharmaceutical Ingredient Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Active Pharmaceutical Ingredient Sales by Manufacturers
3.1.1 Active Pharmaceutical Ingredient Sales by Manufacturers
3.1.2 Active Pharmaceutical Ingredient Sales Market Share by Manufacturers
3.1.3 Global Active Pharmaceutical Ingredient Market Concentration Ratio (CR5 and HHI)
3.2 Active Pharmaceutical Ingredient Revenue by Manufacturers
3.2.1 Active Pharmaceutical Ingredient Revenue by Manufacturers (2015-2020)
3.2.2 Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2015-2020)
3.3 Active Pharmaceutical Ingredient Price by Manufacturers
3.4 Active Pharmaceutical Ingredient Manufacturing Base Distribution, Product Types
3.4.1 Active Pharmaceutical Ingredient Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Active Pharmaceutical Ingredient Product Type
3.4.3 Date of International Manufacturers Enter into Active Pharmaceutical Ingredient Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Active Pharmaceutical Ingredient Sales by Product
4.2 Global Active Pharmaceutical Ingredient Revenue by Product
4.3 Active Pharmaceutical Ingredient Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Active Pharmaceutical Ingredient Breakdown Data by End User
6 North America
6.1 North America Active Pharmaceutical Ingredient by Countries
6.1.1 North America Active Pharmaceutical Ingredient Sales by Countries
6.1.2 North America Active Pharmaceutical Ingredient Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Active Pharmaceutical Ingredient by Product
6.3 North America Active Pharmaceutical Ingredient by End User
7 Europe
7.1 Europe Active Pharmaceutical Ingredient by Countries
7.1.1 Europe Active Pharmaceutical Ingredient Sales by Countries
7.1.2 Europe Active Pharmaceutical Ingredient Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Active Pharmaceutical Ingredient by Product
7.3 Europe Active Pharmaceutical Ingredient by End User
8 Asia Pacific
8.1 Asia Pacific Active Pharmaceutical Ingredient by Countries
8.1.1 Asia Pacific Active Pharmaceutical Ingredient Sales by Countries
8.1.2 Asia Pacific Active Pharmaceutical Ingredient Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Active Pharmaceutical Ingredient by Product
8.3 Asia Pacific Active Pharmaceutical Ingredient by End User
9 Central & South America
9.1 Central & South America Active Pharmaceutical Ingredient by Countries
9.1.1 Central & South America Active Pharmaceutical Ingredient Sales by Countries
9.1.2 Central & South America Active Pharmaceutical Ingredient Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Active Pharmaceutical Ingredient by Product
9.3 Central & South America Active Pharmaceutical Ingredient by End User
10 Middle East and Africa
10.1 Middle East and Africa Active Pharmaceutical Ingredient by Countries
10.1.1 Middle East and Africa Active Pharmaceutical Ingredient Sales by Countries
10.1.2 Middle East and Africa Active Pharmaceutical Ingredient Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Active Pharmaceutical Ingredient by Product
10.3 Middle East and Africa Active Pharmaceutical Ingredient by End User
11 Company Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Company Business Overview
11.1.3 Teva Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Teva Active Pharmaceutical Ingredient Products Offered
11.1.5 Teva Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Company Business Overview
11.2.3 Novartis Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis Active Pharmaceutical Ingredient Products Offered
11.2.5 Novartis Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Company Business Overview
11.3.3 Pfizer Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer Active Pharmaceutical Ingredient Products Offered
11.3.5 Pfizer Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Company Business Overview
11.4.3 Johnson & Johnson Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Johnson & Johnson Active Pharmaceutical Ingredient Products Offered
11.4.5 Johnson & Johnson Recent Development
11.5 Mylan
11.5.1 Mylan Company Details
11.5.2 Company Business Overview
11.5.3 Mylan Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Mylan Active Pharmaceutical Ingredient Products Offered
11.5.5 Mylan Recent Development
11.6 North China Pharmaceutical Group
11.6.1 North China Pharmaceutical Group Company Details
11.6.2 Company Business Overview
11.6.3 North China Pharmaceutical Group Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
11.6.4 North China Pharmaceutical Group Active Pharmaceutical Ingredient Products Offered
11.6.5 North China Pharmaceutical Group Recent Development
11.7 Dr. Reddy\'s Laboratories
11.7.1 Dr. Reddy\'s Laboratories Company Details
11.7.2 Company Business Overview
11.7.3 Dr. Reddy\'s Laboratories Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Dr. Reddy\'s Laboratories Active Pharmaceutical Ingredient Products Offered
11.7.5 Dr. Reddy\'s Laboratories Recent Development
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Company Business Overview
11.8.3 Roche Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Roche Active Pharmaceutical Ingredient Products Offered
11.8.5 Roche Recent Development
11.9 Aurobindo pharma
11.9.1 Aurobindo pharma Company Details
11.9.2 Company Business Overview
11.9.3 Aurobindo pharma Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Aurobindo pharma Active Pharmaceutical Ingredient Products Offered
11.9.5 Aurobindo pharma Recent Development
11.10 Sun Pharmaceutical Industries
11.10.1 Sun Pharmaceutical Industries Company Details
11.10.2 Company Business Overview
11.10.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Products Offered
11.10.5 Sun Pharmaceutical Industries Recent Development
11.11 Boehringer Ingelheim GmbH
11.12 Bayer
11.13 BASF
11.14 DSM
11.15 Zhejiang Medicine
11.16 Biocon
11.17 Johnson Matthey
11.18 Hisun Pharmacy
11.19 Cambrex
11.20 Shandong Xinhua Pharmaceutical
11.21 Lonza group
11.22 Huahai Pharmaceutical
11.23 Haerbin Pharmaceutical Group
11.24 Cipla
11.25 Tian Yao
11.26 Lupin
11.27 North East Pharmaceutical
11.28 Albemarle
11.29 Shandong Lukang Pharmaceutical
11.30 Jiangsu Hengrui Medicine
12 Future Forecast
12.1 Active Pharmaceutical Ingredient Market Forecast by Regions
12.1.1 Global Active Pharmaceutical Ingredient Sales Forecast by Regions 2021-2028
12.1.2 Global Active Pharmaceutical Ingredient Revenue Forecast by Regions 2021-2028
12.2 Active Pharmaceutical Ingredient Market Forecast by Product
12.2.1 Global Active Pharmaceutical Ingredient Sales Forecast by Product 2021-2028
12.2.2 Global Active Pharmaceutical Ingredient Revenue Forecast by Product 2021-2028
12.3 Active Pharmaceutical Ingredient Market Forecast by End User
12.4 North America Active Pharmaceutical Ingredient Forecast
12.5 Europe Active Pharmaceutical Ingredient Forecast
12.6 Asia Pacific Active Pharmaceutical Ingredient Forecast
12.7 Central & South America Active Pharmaceutical Ingredient Forecast
12.8 Middle East and Africa Active Pharmaceutical Ingredient Forecast